Curating evidence-based lifestyle recommendations is key to achieving ideal cardiometabolic health in patients with obesity, ...

Cobenfy’s efficacy at treating the symptoms of patients with psychosis may vary between subgroups, according to a post-hoc ...

The FDA has approved berotralstat oral pellets for prophylactic use in patients aged 2 to than 12 years with hereditary ...

Recent evidence supports repeated corneal cross-linking as an effective and safe option for patients with progressive ectasia ...

For the first time in nearly 40 years, the FDA approved a new antibiotic to treat gonorrhea, an STI that has grown ...

Patients with systemic lupus erythematosus and diabetes who received sodium-glucose cotransporter 2 inhibitors exhibited ...

A 19-year-old man presented with left upper extremity pain and weakness experienced for more than 1 year.He reported this ...

The FDA is proposing to add bemotrizinol to the list of permitted active ingredients for use in sunscreens, according to a ...

A peripherally acting cannabinoid receptor 1 antibody combined with semaglutide induced significant weight loss for adults ...

Adolescent idiopathic scoliosis is the most prevalent spinal deformity in children, with an incidence reported between 0.47% ...

A digital toolkit with patient scripts, risk calculator comparisons and more could help primary care and OB/GYN providers ...

In this video from the American Academy of Ophthalmology meeting, Michael W. Stewart, MD, professor and chairman of ...